This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Possible investigations in possible heart failure include:

  • chest radiology

  • the ECG - is recommended in every patient with suspected HF (1), may elucidate the cause of heart failure:
    • left ventricular hypertrophy which may be caused by chronic hypertension or aortic stenosis
    • evidence of ischaemic heart disease
    • p-mitrale of mitral stenosis

  • echocardiography identifies:
    • focal or diffuse myocardial dysfunction
    • valvular disease
    • pericardial disease
    • left ventricular systolic dysfunction

  • biochemistry, haematology and urinalysis:
    • defines electrolyte disturbances and assesses renal function
    • excludes anaemia
    • exclude thyrotoxicosis in patients with atrial fibrillation
    • excludes causes of oedema such as liver disease, nephrotic syndrome and acute renal failure
    • natriuretic peptides - testing for Brain-type natriuretic peptide (BNP), atrial natriuretic peptide (ANP), and N-terminal (NT)-ANP has been shown to increase the reliability of diagnosis of heart failure in primary care
      • these peptides are released from ventricular myocytes in response to volume overload (stretch), and their concentration has been shown to an extremely sensitive marker for heart failure

  • Other possible investigations include:
    • radionuclide ventriculography e.g. MUGA scan
    • a myocardial biopsy to obtain histological data

NICE have suggested that investigations chosen in primary care depend on whether there is a past history of myocardial infarction. NICE suggest to (1):

  • refer patients with suspected heart failure and previous myocardial infarction (MI) urgently, to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks

  • measure serum natriuretic peptides (B-type natriuretic peptide [BNP] or N-terminal pro-B-type natriuretic peptide [NTproBNP]) in patients with suspected heart failure without previous MI

  • because very high levels of serum natriuretic peptides carry a poor prognosis, refer patients with suspected heart failure and a BNP level above 400 pg/ml (116 pmol/litre) or an NTproBNP level above 2000 pg/ml (236 pmol/litre) urgently, to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks

  • refer patients with suspected heart failure and a BNP level between 100 and 400 pg/ml (29-116 pmol/litre) or an NTproBNP level between 400 and 2000 pg/ml (47-236 pmol/litre) to have transthoracic Doppler 2D echocardiography and specialist assessment within 6 weeks Perform an ECG in all patients and consider the following tests to evaluate possible aggravating factors and/or alternative diagnoses: When a diagnosis of heart failure has been made, assess severity, aetiology, precipitating factors, type of cardiac dysfunction and correctable causes
    • chest X-ray
    • blood tests:
      • electrolytes, urea and creatinine - eGFR (estimated glomerular filtration rate)
      • thyroid function tests
      • liver function tests
      • fasting lipids
      • fasting glucose
      • full blood count
      • urinalysis
      • peak flow or spirometry

Notes:

  • serum natriuretic peptides:
    • obesity or treatment with diuretics, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, angiotensin II receptor antagonists (ARBs) and aldosterone antagonists can reduce levels of serum natriuretic peptides

    • high levels of serum natriuretic peptides can have causes other than heart failure (for example, left ventricular hypertrophy, ischaemia, tachycardia, right ventricular overload, hypoxaemia [including pulmonary embolism], renal dysfunction [GFR < 60 ml/minute], sepsis, chronic obstructive pulmonary disease [COPD], diabetes, age > 70 years and cirrhosis of the liver)

    • a serum BNP level less than 100 pg/ml (29 pmol/litre) or an NTproBNP level less than 400 pg/ml (47 pmol/litre) in an untreated patient makes a diagnosis of heart failure unlikely

    • the level of serum natriuretic peptide does not differentiate between heart failure due to left ventricular systolic dysfunction and heart failure with preserved left ventricular ejection fraction

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.